121 related articles for article (PubMed ID: 31588852)
1. Characterization of an engineered water-soluble variant of the full-length human mu opioid receptor.
Xi J; Xiao J; Perez-Aguilar JM; Ping J; Johnson ATC; Saven JG; Liu R
J Biomol Struct Dyn; 2020 Sep; 38(14):4364-4370. PubMed ID: 31588852
[TBL] [Abstract][Full Text] [Related]
2. Novel variants of engineered water soluble mu opioid receptors with extensive mutations and removal of cysteines.
Xi J; Yang N; Perez-Aguilar JM; Selling B; Grothusen JR; Lamichhane R; Saven JG; Liu R
Proteins; 2021 Oct; 89(10):1386-1393. PubMed ID: 34152652
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a computationally designed water-soluble human μ-opioid receptor variant using available structural information.
Zhao X; Perez-Aguilar JM; Matsunaga F; Lerner M; Xi J; Selling B; Johnson AT; Saven JG; Liu R
Anesthesiology; 2014 Oct; 121(4):866-75. PubMed ID: 24835677
[TBL] [Abstract][Full Text] [Related]
4. A computationally designed water-soluble variant of a G-protein-coupled receptor: the human mu opioid receptor.
Perez-Aguilar JM; Xi J; Matsunaga F; Cui X; Selling B; Saven JG; Liu R
PLoS One; 2013; 8(6):e66009. PubMed ID: 23799068
[TBL] [Abstract][Full Text] [Related]
5. The C-terminus of the mu opioid receptor is critical in G-protein interaction as demonstrated by a novel graphene biosensor.
Wen C; Selling B; Yeliseev A; Xi J; Perez-Aguilar JM; Gao Z; Saven JG; Johnson ATC; Liu R
IEEE Sens J; 2021 Mar; 21(5):5758-5762. PubMed ID: 33679256
[TBL] [Abstract][Full Text] [Related]
6. Expression and purification of functional human mu opioid receptor from E.coli.
Ma Y; Kubicek J; Labahn J
PLoS One; 2013; 8(2):e56500. PubMed ID: 23437147
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal end truncated mu-opioid receptor: from expression to circular dichroism analysis.
Muller I; Sarramégna V; Milon A; Talmont FJ
Appl Biochem Biotechnol; 2010 Apr; 160(7):2175-86. PubMed ID: 19636522
[TBL] [Abstract][Full Text] [Related]
8. Optimized Proteomic Mass Spectrometry Characterization of Recombinant Human μ-Opioid Receptor Functionally Expressed in Pichia pastoris Cell Lines.
Rosa M; Bech-Serra JJ; Canals F; Zajac JM; Talmont F; Arsequell G; Valencia G
J Proteome Res; 2015 Aug; 14(8):3162-73. PubMed ID: 26090583
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors.
Xu W; Li J; Chen C; Huang P; Weinstein H; Javitch JA; Shi L; de Riel JK; Liu-Chen LY
Biochemistry; 2001 Jul; 40(27):8018-29. PubMed ID: 11434771
[TBL] [Abstract][Full Text] [Related]
10. Expression of delta, kappa and mu human opioid receptors in Escherichia coli and reconstitution of the high-affinity state for agonist with heterotrimeric G proteins.
Stanasila L; Massotte D; Kieffer BL; Pattus F
Eur J Biochem; 1999 Mar; 260(2):430-8. PubMed ID: 10095778
[TBL] [Abstract][Full Text] [Related]
11. Expression and spectroscopic characterization of a large fragment of the mu-opioid receptor.
Kerman A; Ananthanarayanan VS
Biochim Biophys Acta; 2005 Feb; 1747(1):133-40. PubMed ID: 15680247
[TBL] [Abstract][Full Text] [Related]
12. Truncated human P450 2D6: expression in Escherichia coli, Ni(2+)-chelate affinity purification, and characterization of solubility and aggregation.
Kempf AC; Zanger UM; Meyer UA
Arch Biochem Biophys; 1995 Aug; 321(2):277-88. PubMed ID: 7646052
[TBL] [Abstract][Full Text] [Related]
13. The opioid ligand binding of human mu-opioid receptor is modulated by novel splice variants of the receptor.
Choi HS; Kim CS; Hwang CK; Song KY; Wang W; Qiu Y; Law PY; Wei LN; Loh HH
Biochem Biophys Res Commun; 2006 May; 343(4):1132-40. PubMed ID: 16580639
[TBL] [Abstract][Full Text] [Related]
14. Refinement of a homology model of the mu-opioid receptor using distance constraints from intrinsic and engineered zinc-binding sites.
Fowler CB; Pogozheva ID; LeVine H; Mosberg HI
Biochemistry; 2004 Jul; 43(27):8700-10. PubMed ID: 15236578
[TBL] [Abstract][Full Text] [Related]
15. Identification of five mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.
Doyle GA; Sheng XR; Lin SS; Press DM; Grice DE; Buono RJ; Ferraro TN; Berrettini WH
Gene; 2007 Jun; 395(1-2):98-107. PubMed ID: 17398041
[TBL] [Abstract][Full Text] [Related]
16. The bovine mu-opioid receptor: cloning of cDNA and pharmacological characterization of the receptor expressed in mammalian cells.
Onoprishvili I; Andria ML; Vilim FS; Hiller JM; Simon EJ
Brain Res Mol Brain Res; 1999 Nov; 73(1-2):129-37. PubMed ID: 10581406
[TBL] [Abstract][Full Text] [Related]
17. Expression of EGFP-amino-tagged human mu opioid receptor in Drosophila Schneider 2 cells: a potential expression system for large-scale production of G-protein coupled receptors.
Perret BG; Wagner R; Lecat S; Brillet K; Rabut G; Bucher B; Pattus F
Protein Expr Purif; 2003 Sep; 31(1):123-32. PubMed ID: 12963349
[TBL] [Abstract][Full Text] [Related]
18. CNS levels of mu opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexone.
Brodsky M; Elliott K; Hynansky A; Inturrisi CE
Brain Res Bull; 1995; 38(2):135-41. PubMed ID: 7583338
[TBL] [Abstract][Full Text] [Related]
19. Mediation of opioid analgesia by a truncated 6-transmembrane GPCR.
Lu Z; Xu J; Rossi GC; Majumdar S; Pasternak GW; Pan YX
J Clin Invest; 2015 Jul; 125(7):2626-30. PubMed ID: 26011641
[TBL] [Abstract][Full Text] [Related]
20. mu Opioid receptor: role for the amino terminus as a determinant of ligand binding affinity.
Chaturvedi K; Shahrestanifar M; Howells RD
Brain Res Mol Brain Res; 2000 Mar; 76(1):64-72. PubMed ID: 10719216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
